Page last updated: 2024-08-23

pravastatin and Stroke

pravastatin has been researched along with Stroke in 85 studies

Research

Studies (85)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (2.35)	18.2507
2000's	60 (70.59)	29.6817
2010's	20 (23.53)	24.3611
2020's	3 (3.53)	2.80

Authors

Authors	Studies
Cassola, N; Clezar, CN; Flumignan, CD; Flumignan, RL; Nakano, LC; Trevisani, VF	1
Hoang, T; Kim, J	1
Chang, CC; Chen, TL; Hu, CJ; Huang, YC; Liao, CC; Lin, CS; Yeh, CC	1
Ahn, CM; Cheong, SS; Cho, DK; Cho, YH; Choi, D; Her, AY; Hong, MK; Im, E; Jang, Y; Kang, WC; Kim, BK; Kim, JS; Kim, YH; Ko, YG; Lee, K; Shin, DH; Suh, Y; Yoo, SY; Yun, KH	1
Aoki, S; Hosomi, N; Kagimura, T; Kitagawa, K; Maruyama, H; Matsumoto, M; Minematsu, K; Nagai, Y; Nakagawa, Y; Nezu, T; Origasa, H; Uchiyama, S	1
Aoki, S; Hosomi, N; Kagimura, T; Kamiyama, K; Kitagawa, K; Koga, M; Maruyama, H; Matsumoto, M; Minematsu, K; Nagai, Y; Nezu, T; Ohtsuki, T; Origasa, H; Suzuki, R; Toyoda, K; Uchiyama, S; Yasaka, M	1
Hosomi, N; Kagimura, T; Kitagawa, K; Maruyama, H; Matsumoto, M; Minematsu, K; Nagai, Y; Nakamura, M; Ohtsuki, T; Origasa, H; Uchiyama, S	1
Aoki, S; Hosomi, N; Kagimura, T; Kitagawa, K; Koga, M; Maruyama, H; Matsumoto, M; Minematsu, K; Nagai, Y; Nezu, T; Ohtsuki, T; Origasa, H; Suzuki, R; Toyoda, K; Uchiyama, S; Wada, S; Yasaka, M	1
de Craen, AJ; Ford, I; Jukema, JW; Lucke, J; Mooijaart, SP; Sattar, N; Stott, DJ; Trompet, S; Westendorp, RG	1
Chertow, GM; Erickson, KF; Garber, AM; Goldhaber-Fiebert, JD; Japa, S; Owens, DK	1
Jha, V; Modi, GK	1
Cobbe, SM; Ford, I; Marchbank, L; McConnachie, A; Packard, CJ; Peacock, J; Robertson, M; Walker, A	1
Fukushima, M; Hosomi, N; Ibayashi, S; Kitagawa, K; Kobayashi, S; Kohriyama, T; Matsubara, Y; Matsumoto, M; Minematsu, K; Mori, E; Nagai, Y; Nakamura, M; Nomura, E; Ohtsuki, T; Origasa, H; Shinohara, Y; Takagi, M; Terayama, Y; Uchiyama, S; Yamaguchi, T; Yamasaki, Y; Yamawaki, T; Yokota, C	1
Blankenberg, S; Colquhoun, D; Hunt, D; Keech, AC; Mann, K; Nestel, P; Simes, J; Stewart, R; Sullivan, D; Thompson, P; Tonkin, A; West, M; White, HD	1
Akao, H; Buckley, BM; de Craen, AJ; Ford, I; Jukema, JW; Kajinami, K; Packard, C; Polisecki, E; Robertson, M; Schaefer, EJ; Trompet, S	1
Aoki, S; Fukushima, M; Hosomi, N; Ibayashi, S; Kitagawa, K; Kohriyama, T; Maruyama, H; Matsumoto, M; Minematsu, K; Mori, E; Nagai, Y; Nakamura, M; Nezu, T; Ohtsuki, T; Origasa, H; Shinohara, Y; Sunami, N; Takagi, M; Terayama, Y; Uchiyama, S; Yamaguchi, T; Yokota, C	1
Hosomi, N; Kitagawa, K; Koga, M; Matsumoto, M; Minematsu, K; Nagai, Y; Origasa, H; Toyoda, K; Uchiyama, S; Yasaka, M	1
Hosomi, N; Kagimura, T; Kitagawa, K; Matsumoto, M; Minematsu, K; Nagai, Y; Nakamura, M; Ohtsuki, T; Origasa, H; Uchiyama, S	1
Ay, H; Dalkara, T; Kirazli, S; Kocaefe, C; Moskowitz, MA; Ozcebe, O; Ozgüç, M; Qui, J; Topalkara, K; Yemisci, M	1
Blauw, GJ; Buckley, BM; de Craen, AJ; Ford, I; Forouhi, NG; Freeman, DJ; Jukema, JW; Macfarlane, PW; Murphy, MB; Murray, HM; Packard, CJ; Sattar, N; Shepherd, J; Stott, DJ; Welsh, P; Westendorp, RG	1
Barnes, EH; Colquhoun, D; Keech, A; Nestel, P; Pollicino, C; Simes, J; Söderberg, S; Tonkin, AM; Yallop, J	1
Kushiro, T; Mizuno, K; Nakamura, H; Nakaya, N; Ohashi, Y; Tajima, N; Teramoto, T; Uchiyama, S	1
Blauw, GJ; Buckley, BM; Cobbe, S; de Craen, AJ; Ford, I; Jukema, JW; Lowe, GD; Macfarlane, PW; Murphy, MB; Murray, HM; Packard, CJ; Sattar, N; Shepherd, J; Stott, DJ; Welsh, P; Westendorp, RG	1
Hennekens, C	1
Hickman, J	1
Braunwald, E; Cannon, CP; McCabe, CH; Murphy, SA; Wiviott, SD	1
Nissen, SE	1
Acharjee, S; Cannon, CP; McCabe, C; Murphy, SA; Qin, J	1
Abe, A; Katayama, Y; Katsura, K; Nagayama, H; Nishiyama, Y; Otsuka, T; Ueda, M	1
Armani, A; Cannon, CP; McCabe, CH; Murphy, SA; Truong, QA	1
Hirahara, K; Mizuno, K; Mizutani, M; Nakamura, H; Nakaya, N; Ohashi, Y; Teramoto, T; Yokoyama, S	1
Gillies, C; Manktelow, B; Potter, JF	1
Liao, JK	1
Farmer, JA; Gotto, AM	1
Anderson, NE; Hankey, GJ; Hunt, D; Kirby, A; Simes, RJ; Tonkin, AM; Watson, JD; West, MJ; White, HD; Wonders, S	1
Curhan, G; Kiberd, B; Moyé, L; Sacks, FM; Tonelli, M	1
Bouzamondo, A; Corvol, JC; Hulot, JS; Lechat, P; Sanchez, P; Sirol, M	1
Clark, LT	1
Baztán, JJ; Hornillos, M; Rodríguez-Mañas, L	1
Diener, HC	1
Arulchelvam, M; Baker, J; Beller, E; Best, J; Colquhoun, D; Hague, W; Hunt, D; Keech, A; Kirby, A; Simes, RJ; Tonkin, A	1
Brown, WV; Moussa, M	1
Belder, R; Berry, DA; Berry, SM; Byington, RP; Fiedorek, FT; Ford, NF; Hennekens, CH; Jukema, JW; Natarajan, K; Pitt, B; Sacks, FM; Sheng-Lin, C; Tonkin, A; Walker, AJ	1
Cheung, BM; Kumana, CR; Lau, CP; Lauder, IJ	1
Byington, RP; Sacks, FM	1
Asselbergs, FW; de Jong, PE; Gans, RO; Hillege, HL; Smit, AJ; van Gilst, WH; van Roon, AM	1
Colquhoun, DM; Heritier, SR; Kirby, AC; Nestel, PJ; Simes, RJ; Stewart, RA; Tonkin, AM; West, MJ; White, HD	1
Hata, T; Ishikawa, K; Kitagawa, Y; Ohta, T; Shinohara, Y; Tomiyasu, H; Yamamoto, M	1
Braunwald, E; DelMonte, T; Devlin, JJ; Dracopoli, NC; Hui, L; Iakoubova, OA; Kirchgessner, TG; Ranade, K; Sabatine, MS; Sacks, FM; Shaw, PM; Tsuchihashi, Z; Vishnupad, P; White, TJ	1
Amarenco, P; Labreuche, J; Lavallée, PC; Touboul, PJ	1
Blazing, M; Braunwald, E; Califf, R; Cannon, CP; de Lemos, JA; McCabe, CH; Murphy, SA; Wiviott, SD	1
Castilla-Guerra, L; Espino-Montoro, A; Fernandez Moreno, Mdel C; Jimérnez, MD; López-Chozas, JM	1
Braunwald, E; Cairns, R; Cannon, CP; Mega, JL; Morrow, DA; Murphy, S; Ridker, PM	1
Carod-Artal, FJ	1
Boukriche, Y; Dumas, C; Nangou, P; Oziol, E; Reny, JL; Sedighian, S; Simorre, B	1
Kohriyama, T; Matsumoto, M; Nomura, E; Ohtsuki, T	1
Berger, C; Maurer, MH; Schwab, S; Xia, F	1
Fukunami, M; Hirayama, A; Hori, M; Ito, H; Kijima, Y; Kinjo, K; Koretsune, Y; Lim, YJ; Mizuno, H; Nakatani, D; Nanto, S; Nishino, M; Sato, H; Shimizu, M	1
Jacobson, TA; Walker, DB	1
Criqui, MH; Dimsdale, JE; Golomb, BA; Ritchie, JB; White, HL	1
Blauw, GJ; Bollen, EL; Buckley, BM; Cobbe, SM; Ford, I; Gaw, A; Hyland, M; Jukema, JW; Lagaay, AM; Macfarlane, PW; Meinders, AE; Murphy, MB; Packard, CJ; Perry, IJ; Shepherd, J; Stott, DJ; Sweeney, BJ; Twomey, C; Westendorp, RG	1
Delanty, N; Mohler, ER; Rader, DJ; Raps, EC	1
Rosenson, RS	1
Anderson, NE; Colquhoun, DM; Glasziou, P; Hankey, GJ; Hunt, D; Kirby, AC; MacMahon, S; Simes, RJ; Tonkin, AM; Watson, JD; West, MJ; White, HD	1
Cockcroft, JR; Wilkinson, IB	1
Agrawal, R; Arntz, HR; Fischer, F; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W	1
Brett, AS	1
Fruchter, O	1
Meilof, JF; Uitdehaag, BM	1
Hau, P; Koch, HJ; Steinbrecher, A	1
Plutzky, J; Ridker, PM	1
Baker, J; Byington, RP; Cobbe, SM; Davis, BR; Plehn, JF; Shepherd, J; White, HD	1
Alberts, MJ	1
Athyros, VG; Kontopoulos, AG; Papageorgiou, AA	1
Waters, DD	1
Bouzamondo, A; Lechat, P; Sanchez, P; Sirol, M	1
Ferbert, A	1
Dumont, AS; Dumont, RJ; Fedak, PM; Hyndman, ME; Kassell, NF; Sutherland, GR; Verma, S	1
Choi-Kwon, S; Kim, JS	1
de Boer, A; Fishman, PA; Heckbert, SR; Klungel, OH; Leufkens, HG; Psaty, BM; Sullivan, SD; Veenstra, DL	1

Reviews

22 review(s) available for pravastatin and Stroke

Article	Year
Pharmacological interventions for asymptomatic carotid stenosis. The Cochrane database of systematic reviews, 2023, 08-04, Volume: 8 Topics: Aspirin; Atherosclerosis; Atorvastatin; Carotid Stenosis; Chlorthalidone; Fluvastatin; Hemorrhage; Humans; Ischemic Stroke; Metoprolol; Pravastatin; Probucol; Rosuvastatin Calcium; Stroke; Warfarin	2023
Comparative Effect of Statins and Omega-3 Supplementation on Cardiovascular Events: Meta-Analysis and Network Meta-Analysis of 63 Randomized Controlled Trials Including 264,516 Participants. Nutrients, 2020, Jul-25, Volume: 12, Issue:8 Topics: Aged; Atorvastatin; Cardiovascular Diseases; Coronary Disease; Dietary Supplements; Fatty Acids, Omega-3; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Network Meta-Analysis; Pravastatin; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome	2020
Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. Journal of the American College of Cardiology, 2013, Mar-26, Volume: 61, Issue:12 Topics: Aged; Cost-Benefit Analysis; Decision Support Techniques; Disease Progression; Drug Costs; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney Failure, Chronic; Male; Markov Chains; Myocardial Infarction; Pravastatin; Primary Prevention; Quality-Adjusted Life Years; Rhabdomyolysis; Risk; Sex Factors; Stroke; United States	2013
[Pravastatin and acetylsalycilic acid fixed-combination: a strategy to improve cardiovascular outcomes]. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2007, Volume: 7 Spec No 1 Topics: Aspirin; Atherosclerosis; Coronary Disease; Drug Combinations; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Platelet Aggregation Inhibitors; Pravastatin; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome	2007
Interventions in the management of serum lipids for preventing stroke recurrence. The Cochrane database of systematic reviews, 2002, Issue:3 Topics: Cardiovascular Diseases; Clofibrate; Estrogens, Conjugated (USP); Humans; Hypolipidemic Agents; Pravastatin; Recurrence; Stroke	2002
Beyond lipid lowering: the role of statins in vascular protection. International journal of cardiology, 2002, Volume: 86, Issue:1 Topics: Animals; Cardiovascular Diseases; Coronary Artery Disease; Endothelium, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neovascularization, Physiologic; Pravastatin; Randomized Controlled Trials as Topic; Simvastatin; Stroke	2002
Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials. Archives of internal medicine, 2003, Mar-24, Volume: 163, Issue:6 Topics: Anticholesteremic Agents; Atorvastatin; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment; Risk Factors; Simvastatin; Stroke; Treatment Failure; Treatment Outcome	2003
Treating dyslipidemia with statins: the risk-benefit profile. American heart journal, 2003, Volume: 145, Issue:3 Topics: Atorvastatin; Cholesterol; Cholesterol, HDL; Coronary Disease; Drug Interactions; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hyperlipidemias; Indoles; Lovastatin; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Risk Assessment; Simvastatin; Stroke; Triglycerides; United States	2003
Perspectives from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial--Lipid Lowering Trial and the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm. Current opinion in lipidology, 2003, Volume: 14, Issue:6 Topics: Aged; Atorvastatin; Cholesterol, LDL; Coronary Artery Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome	2003
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses. Archives of internal medicine, 2004, Jan-12, Volume: 164, Issue:1 Topics: Aged; Anticholesteremic Agents; Aspirin; Cardiovascular Diseases; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Pravastatin; Randomized Controlled Trials as Topic; Risk Factors; Stroke	2004
Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. British journal of clinical pharmacology, 2004, Volume: 57, Issue:5 Topics: Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Randomized Controlled Trials as Topic; Sex Factors; Smoking; Stroke	2004
Lessons learned from the prospective pravastatin pooling project. Current atherosclerosis reports, 2004, Volume: 6, Issue:5 Topics: Adult; Aged; Coronary Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lipid Metabolism; Male; Middle Aged; Pravastatin; Prospective Studies; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome	2004
Stroke prevention, blood cholesterol and statins. Acta neurologica Taiwanica, 2005, Volume: 14, Issue:3 Topics: Atorvastatin; Cholesterol; Clinical Trials as Topic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Pyrroles; Risk Factors; Stroke	2005
[J-STARS (Japan statin treatment against recurrent stroke)]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Oct-28, Volume: 64 Suppl 7 Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Middle Aged; Pravastatin; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Stroke	2006
Neuroprotection by pravastatin in acute ischemic stroke in rats. Brain research reviews, 2008, Volume: 58, Issue:1 Topics: Animals; Anticholesteremic Agents; Brain Ischemia; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Pravastatin; Rats; Rats, Wistar; Stroke; Treatment Outcome	2008
Initiating statins in the elderly: the evolving challenge. Current opinion in endocrinology, diabetes, and obesity, 2008, Volume: 15, Issue:2 Topics: Aged; Clinical Trials as Topic; Coronary Disease; Diabetic Angiopathies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Pravastatin; Primary Prevention; Safety; Stroke	2008
Statins and cerebrovascular disease: plaque attack to prevent brain attack. Vascular medicine (London, England), 1999, Volume: 4, Issue:4 Topics: Adult; Aged; Anticholesteremic Agents; Blood Vessels; Clinical Trials as Topic; Humans; Hypercholesterolemia; Lovastatin; Middle Aged; Pravastatin; Stroke	1999
Biological basis for statin therapy in stroke prevention. Current opinion in neurology, 2000, Volume: 13, Issue:1 Topics: Animals; Humans; Lovastatin; Pravastatin; Simvastatin; Stroke	2000
Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project. Circulation, 2001, Jan-23, Volume: 103, Issue:3 Topics: Anticholesteremic Agents; Coronary Disease; Humans; Male; Pravastatin; Proportional Hazards Models; Prospective Studies; Stroke; Time Factors	2001
What do the statin trials tell us? The American journal of managed care, 2001, Volume: 7, Issue:5 Suppl Topics: Anticholesteremic Agents; Clinical Trials as Topic; Coronary Disease; Female; Humans; Hypercholesterolemia; Lipoproteins, LDL; Lovastatin; Male; Outcome Assessment, Health Care; Pravastatin; Stroke; United States	2001
[Does statin therapy reduce the risk of stroke? A meta-analysis]. Annales de medecine interne, 2001, Volume: 152, Issue:3 Topics: Age Distribution; Cardiovascular Diseases; Cause of Death; Effect Modifier, Epidemiologic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Pravastatin; Primary Prevention; Risk; Risk Factors; Simvastatin; Stroke; Survival Analysis; Treatment Outcome	2001
[Stroke, cholesterol and statins--are there new data about stroke prevention?]. Deutsche medizinische Wochenschrift (1946), 2001, Jun-01, Volume: 126, Issue:22 Topics: Anticholesteremic Agents; Blood Pressure; Cholesterol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Pravastatin; Risk Factors; Stroke	2001

Trials

35 trial(s) available for pravastatin and Stroke

Article	Year
High-intensity Statin Treatments in Clinically Stable Patients on Aspirin Monotherapy 12 Months After Drug-eluting Stent Implantation: A Randomized Study. Revista espanola de cardiologia (English ed.), 2018, Volume: 71, Issue:6 Topics: Aspirin; Atorvastatin; Coronary Artery Disease; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Pravastatin; Stroke; Treatment Outcome	2018
Pravastatin Reduces the Risk of Atherothrombotic Stroke when Administered within Six Months of an Initial Stroke Event. Journal of atherosclerosis and thrombosis, 2018, Mar-01, Volume: 25, Issue:3 Topics: Aged; Aged, 80 and over; Cohort Studies; Drug Administration Schedule; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Japan; Male; Middle Aged; Pravastatin; Proportional Hazards Models; Recurrence; Risk; Stroke; Thrombosis; Time Factors	2018
Long-Term Effect of Pravastatin on Carotid Intima-Media Complex Thickness: The J-STARS Echo Study (Japan Statin Treatment Against Recurrent Stroke). Stroke, 2018, Volume: 49, Issue:1 Topics: Aged; Aged, 80 and over; Asian People; Brain Ischemia; Carotid Intima-Media Thickness; Female; Humans; Japan; Male; Middle Aged; Pravastatin; Stroke; Time Factors	2018
Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA. Journal of atherosclerosis and thrombosis, 2019, May-01, Volume: 26, Issue:5 Topics: Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Cholesterol, LDL; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Ischemic Attack, Transient; Japan; Male; Pravastatin; Prognosis; Prospective Studies; Recurrence; Stroke	2019
Baseline Carotid Intima-Media Thickness and Stroke Recurrence During Secondary Prevention With Pravastatin. Stroke, 2019, Volume: 50, Issue:6 Topics: Aged; Brain Infarction; Carotid Intima-Media Thickness; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pravastatin; Recurrence; Stroke	2019
Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study. Journal of internal medicine, 2013, Volume: 274, Issue:1 Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cognition; Cognition Disorders; Confounding Factors, Epidemiologic; Cross-Sectional Studies; Executive Function; Female; Follow-Up Studies; Genotype; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Inflammation; Interleukin-6; Ireland; Male; Netherlands; Neuropsychological Tests; Polymorphism, Single Nucleotide; Pravastatin; Promoter Regions, Genetic; Risk Assessment; Risk Factors; Scotland; Stroke	2013
Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study. European heart journal, 2014, Volume: 35, Issue:5 Topics: Cardiovascular Diseases; Cost-Benefit Analysis; Health Resources; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pravastatin; Primary Prevention; Quality-Adjusted Life Years; State Medicine; Stroke; Treatment Outcome	2014
Rationale, design, and baseline features of a randomized controlled trial to assess the effects of statin for the secondary prevention of stroke: the Japan Statin Treatment Against Recurrent Stroke (J-STARS). International journal of stroke : official journal of the International Stroke Society, 2014, Volume: 9, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Enzyme Inhibitors; Female; Humans; Japan; Longitudinal Studies; Male; Middle Aged; Outpatients; Pravastatin; Secondary Prevention; Severity of Illness Index; Statistics, Nonparametric; Stroke; Treatment Outcome	2014
Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Journal of the American College of Cardiology, 2014, Feb-04, Volume: 63, Issue:4 Topics: Adult; Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Coronary Disease; Follow-Up Studies; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Multivariate Analysis; Myocardial Infarction; Natriuretic Peptide, Brain; Pravastatin; Risk Assessment; Stroke; Troponin I	2014
ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment. Atherosclerosis, 2014, Volume: 235, Issue:1 Topics: Aged; Alleles; ATP Binding Cassette Transporter 1; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Genotype; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Polymorphism, Single Nucleotide; Pravastatin; Proportional Hazards Models; Stroke	2014
The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study. EBioMedicine, 2015, Volume: 2, Issue:9 Topics: Aged; Asian People; Brain Ischemia; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Pravastatin; Proportional Hazards Models; Recurrence; Stroke	2015
The Japan Statin Treatment Against Recurrent Stroke (J-STARS) Echo Study: Rationale and Trial Protocol. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2017, Volume: 26, Issue:3 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Carotid Arteries; Carotid Intima-Media Thickness; Clinical Protocols; Female; Follow-Up Studies; Humans; Hyperlipidemias; Japan; Male; Middle Aged; Outcome Assessment, Health Care; Pravastatin; Recurrence; Statistics, Nonparametric; Stroke; Ultrasonography	2017
Reduction in High-Sensitivity C-Reactive Protein Levels in Patients with Ischemic Stroke by Statin Treatment: Hs-CRP Sub-Study in J-STARS. Journal of atherosclerosis and thrombosis, 2017, Oct-01, Volume: 24, Issue:10 Topics: Aged; Aged, 80 and over; Brain Ischemia; C-Reactive Protein; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Inflammation; Male; Middle Aged; Pravastatin; Recurrence; Risk; Stroke	2017
Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels. Cerebrovascular diseases (Basel, Switzerland), 2008, Volume: 26, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Arginine; Bleeding Time; Blood Platelets; Brain Ischemia; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Ornithine; Platelet Aggregation; Pravastatin; RNA, Messenger; Stroke; Treatment Outcome	2008
Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study. International journal of obesity (2005), 2009, Volume: 33, Issue:1 Topics: Adiponectin; Aged; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leptin; Logistic Models; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Pravastatin; Recurrence; Risk; Stroke	2009
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? PLoS medicine, 2009, Jun-23, Volume: 6, Issue:6 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Kaplan-Meier Estimate; Male; Myocardial Infarction; Pravastatin; Risk Factors; Stroke	2009
Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection T Journal of the American College of Cardiology, 2009, Dec-15, Volume: 54, Issue:25 Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cholesterol; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Myocardial Revascularization; Pravastatin; Pyrroles; Regression Analysis; Secondary Prevention; Stroke	2009
Distribution of traditional and novel risk factors and their relation to subsequent cardiovascular events in patients with acute coronary syndromes (from the PROVE IT-TIMI 22 trial). The American journal of cardiology, 2010, Mar-01, Volume: 105, Issue:5 Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Cholesterol; Cohort Studies; Female; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Pravastatin; Pyrroles; Risk Factors; Stroke; Treatment Outcome	2010
Statin treatment decreased serum asymmetric dimethylarginine (ADMA) levels in ischemic stroke patients. Journal of atherosclerosis and thrombosis, 2011, Volume: 18, Issue:2 Topics: Aged; Aged, 80 and over; Arginine; Atherosclerosis; Atorvastatin; Brain Ischemia; Cholesterol, LDL; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Linear Models; Male; Middle Aged; Pravastatin; Prospective Studies; Pyrroles; Quinolines; Stroke	2011
Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22. Circulation. Cardiovascular quality and outcomes, 2011, Volume: 4, Issue:3 Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Atorvastatin; Biomarkers; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Sex Characteristics; Stroke; Treatment Outcome	2011
Low-dose pravastatin and age-related differences in risk factors for cardiovascular disease in hypercholesterolaemic Japanese: analysis of the management of elevated cholesterol in the primary prevention group of adult Japanese (MEGA study). Drugs & aging, 2011, Sep-01, Volume: 28, Issue:9 Topics: Adult; Age Factors; Aged; Asian People; Cardiovascular Diseases; Cholesterol; Coronary Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Risk Factors; Stroke	2011
Risk factors for non-haemorrhagic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatin. Journal of hypertension, 2002, Volume: 20, Issue:12 Topics: Aged; Anticholesteremic Agents; Blood Pressure; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Pravastatin; Prognosis; Risk Factors; Stroke	2002
Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. Annals of internal medicine, 2003, Jan-21, Volume: 138, Issue:2 Topics: Aged; Cardiovascular Diseases; Creatinine; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Patient Compliance; Pravastatin; Stroke	2003
Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial. Diabetes care, 2003, Volume: 26, Issue:10 Topics: Adult; Aged; Angina, Unstable; Anticholesteremic Agents; Blood Glucose; Cardiovascular Diseases; Coronary Artery Disease; Coronary Restenosis; Diabetes Mellitus, Type 2; Fasting; Female; Follow-Up Studies; Glucose Intolerance; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Pravastatin; Risk Factors; Stroke; Treatment Outcome	2003
Effects of fosinopril and pravastatin on carotid intima-media thickness in subjects with increased albuminuria. Stroke, 2005, Volume: 36, Issue:3 Topics: Albuminuria; Carotid Artery, Common; Double-Blind Method; Female; Fosinopril; Humans; Male; Middle Aged; Pravastatin; Predictive Value of Tests; Stroke; Tunica Intima; Tunica Media	2005
White blood cell count predicts reduction in coronary heart disease mortality with pravastatin. Circulation, 2005, Apr-12, Volume: 111, Issue:14 Topics: Aged; Biomarkers; Coronary Disease; Female; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Pravastatin; Predictive Value of Tests; Prognosis; Stroke; Survival Rate	2005
Effect of anticholesterol therapy on soluble ICAM-1 in chronic stroke patients with hyperlipidemia. The Tokai journal of experimental and clinical medicine, 2005, Volume: 30, Issue:1 Topics: Aged; Anticholesteremic Agents; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Chronic Disease; Female; Humans; Hyperlipidemias; Intercellular Adhesion Molecule-1; Male; Pravastatin; Solubility; Stroke; Triglycerides	2005
Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy. Journal of thrombosis and thrombolysis, 2006, Volume: 22, Issue:1 Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cholesterol; Epidemiologic Methods; Female; Fluoroquinolones; Gatifloxacin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Stroke	2006
Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: the OACIS-LIPID Study. Circulation journal : official journal of the Japanese Circulation Society, 2008, Volume: 72, Issue:1 Topics: Aged; Angina, Unstable; Death; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Pravastatin; Secondary Prevention; Stroke; Treatment Outcome	2008
Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial. Archives of internal medicine, 2008, Apr-14, Volume: 168, Issue:7 Topics: Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diastole; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Pravastatin; Simvastatin; Stroke; Systole; Treatment Outcome	2008
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. The American journal of cardiology, 1999, Nov-15, Volume: 84, Issue:10 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Double-Blind Method; Female; Humans; Male; Pravastatin; Prospective Studies; Stroke	1999
Pravastatin therapy and the risk of stroke. The New England journal of medicine, 2000, Aug-03, Volume: 343, Issue:5 Topics: Adult; Aged; Anticholesteremic Agents; Brain Ischemia; Cerebral Hemorrhage; Coronary Disease; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Pravastatin; Risk Factors; Severity of Illness Index; Stroke	2000
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). The American journal of cardiology, 2000, Dec-15, Volume: 86, Issue:12 Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Chemoprevention; Chi-Square Distribution; Cholesterol, LDL; Cholestyramine Resin; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Drug Combinations; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Niacin; Odds Ratio; Peripheral Vascular Diseases; Pravastatin; Regression Analysis; Statistics, Nonparametric; Stroke; Survival Rate; Treatment Outcome	2000
Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project. Circulation, 2001, Jan-23, Volume: 103, Issue:3 Topics: Anticholesteremic Agents; Coronary Disease; Humans; Male; Pravastatin; Proportional Hazards Models; Prospective Studies; Stroke; Time Factors	2001
Statin-fibrate combinations in patients with combined hyperlipedemia. Atherosclerosis, 2001, Volume: 155, Issue:1 Topics: Clofibric Acid; Coronary Disease; Drug Therapy, Combination; Fibric Acids; Follow-Up Studies; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Myocardial Infarction; Pravastatin; Simvastatin; Stroke	2001

Other Studies

29 other study(ies) available for pravastatin and Stroke

Article	Year
The protective effect of statins against pressure ulcers in stroke patients: A propensity-score matched study based on a real-world database. Atherosclerosis, 2021, Volume: 317 Topics: Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pravastatin; Pressure Ulcer; Retrospective Studies; Stroke	2021
Cardiovascular disease: The price of a QALY--cost-effectiveness of statins in CKD. Nature reviews. Nephrology, 2013, Volume: 9, Issue:7 Topics: Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Myocardial Infarction; Pravastatin; Rhabdomyolysis; Stroke	2013
Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly. Diabetologia, 2009, Volume: 52, Issue:2 Topics: Aged; Aged, 80 and over; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Intercellular Adhesion Molecule-1; Male; Myocardial Infarction; Pravastatin; Predictive Value of Tests; Prospective Studies; Risk Factors; Stroke; Time Factors	2009
Risk factors for stroke and lipid-lowering effect of pravastatin on the risk of stroke in Japanese patients with hypercholesterolemia: analysis of data from the MEGA Study, a large randomized controlled trial. Journal of the neurological sciences, 2009, Sep-15, Volume: 284, Issue:1-2 Topics: Adult; Aged; Alcohol Drinking; Cholesterol; Combined Modality Therapy; Comorbidity; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Incidence; Japan; Lipoprotein(a); Male; Middle Aged; Obesity; Pravastatin; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Smoking; Stroke	2009
Rosuvastatin for cardiovascular prevention: too many uncertainties. Prescrire international, 2009, Volume: 18, Issue:102 Topics: Aged; Angina, Unstable; Anticholesteremic Agents; Cardiovascular Diseases; Diabetes Mellitus; Double-Blind Method; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Pravastatin; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Simvastatin; Stroke; Sulfonamides; Uncertainty	2009
Does higher usage of low-cost statins correlate with a poorer achievement in cholesterol quality markers for secondary prevention? The British journal of general practice : the journal of the Royal College of General Practitioners, 2010, Volume: 60, Issue:570 Topics: Cardiovascular Diseases; Drug Costs; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Outcome and Process Assessment, Health Care; Pravastatin; Secondary Prevention; Simvastatin; Stroke	2010
Cardiovascular outcomes in randomized trials: should time to first event for "hard" end points remain the standard approach? Journal of the American College of Cardiology, 2009, Dec-15, Volume: 54, Issue:25 Topics: Atorvastatin; Cardiovascular Diseases; Cholesterol; Endpoint Determination; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Revascularization; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Time Factors	2009
Reducing the risk for stroke in patients with myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy. Circulation, 2002, Sep-24, Volume: 106, Issue:13 Topics: Cholesterol; Clinical Trials as Topic; Cohort Studies; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Meta-Analysis as Topic; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Pravastatin; Prospective Studies; Risk Assessment; Risk Factors; Scandinavian and Nordic Countries; Stroke; Survival Rate; Time; United States	2002
More on PROSPER. Lancet (London, England), 2003, Mar-29, Volume: 361, Issue:9363 Topics: Age Factors; Aged; Anticholesteremic Agents; Coronary Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome	2003
Statins: new data in secondary prevention and diabetes. Pravastatin and simvastatin are the best-assessed statins. Prescrire international, 2003, Volume: 12, Issue:66 Topics: Aged; Anticholesteremic Agents; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus; Drug Evaluation; Heptanoic Acids; Humans; Hypertension; Pravastatin; Pyrroles; Rhabdomyolysis; Simvastatin; Stroke; Treatment Outcome	2003
[Primary prevention of stroke. What helps--what does not help? The guidelines of the German Society of Neurology briefly summarized]. MMW Fortschritte der Medizin, 2003, Volume: 145 Suppl 1 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Alcohol Drinking; Anticholesteremic Agents; Anticoagulants; Antihypertensive Agents; Arrhythmias, Cardiac; Aspirin; Atenolol; Atrial Fibrillation; Carotid Artery, Internal; Carotid Stenosis; Chlorthalidone; Clinical Trials as Topic; Diabetes Complications; Diuretics; Doxazosin; Female; Fibrinolytic Agents; Hormone Replacement Therapy; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Life Style; Losartan; Male; Neurology; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pravastatin; Primary Prevention; Risk Factors; Simvastatin; Smoking; Societies, Medical; Stroke	2003
Clash of the statins? A trial pitting two popular statins against each other helps answer a far more important question: how low should cholesterol go? Harvard heart letter : from Harvard Medical School, 2004, Volume: 14, Issue:6 Topics: Arteriosclerosis; Atorvastatin; Cholesterol, LDL; Clinical Trials as Topic; Disease Progression; Heptanoic Acids; Humans; Hypolipidemic Agents; Myocardial Infarction; Pravastatin; Pyrroles; Reference Values; Stroke	2004
How low should your cholesterol go? Even lower may be better. For those at highest risk, very low cholesterol levels may help prevent a second heart attack or stroke. Health news (Waltham, Mass.), 2004, Volume: 10, Issue:10 Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol; Heptanoic Acids; Humans; Myocardial Infarction; Pravastatin; Pyrroles; Reference Values; Stroke	2004
Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke. Stroke, 2005, Volume: 36, Issue:11 Topics: Arginine; Aryldialkylphosphatase; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Glutamine; Heterozygote; Homozygote; Humans; Lipoproteins, LDL; Male; Multivariate Analysis; Odds Ratio; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Pravastatin; Risk; Risk Factors; Stroke	2005
Statins for high-risk patients without heart disease or high cholesterol. The Medical letter on drugs and therapeutics, 2006, Jan-02, Volume: 48, Issue:1225 Topics: Atorvastatin; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus, Type 2; Drug Interactions; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Pravastatin; Pyrroles; Simvastatin; Stroke	2006
A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22. Circulation, 2006, Mar-21, Volume: 113, Issue:11 Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Case Management; Chemical and Drug Induced Liver Injury; Comorbidity; Confounding Factors, Epidemiologic; Dose-Response Relationship, Drug; Endpoint Determination; Female; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Tables; Lipids; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design; Risk; Risk Factors; Simvastatin; Stroke; Tirofiban; Treatment Outcome; Tyrosine	2006
Statins and stroke: current clinical practice. Stroke, 2006, Volume: 37, Issue:5 Topics: Age Factors; Atorvastatin; Cholesterol; Clinical Trials as Topic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Pyrroles; Secondary Prevention; Simvastatin; Stroke	2006
Statins and cerebral vasomotor reactivity: implications for a new therapy? Stroke, 2006, Volume: 37, Issue:10 Topics: Adult; Animals; Arginine; Atorvastatin; Brain Ischemia; Cerebrovascular Circulation; Clinical Trials, Phase II as Topic; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Intracranial Aneurysm; Mice; Middle Cerebral Artery; Nitric Oxide; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Simvastatin; Stroke; Subarachnoid Hemorrhage; Ultrasonography, Doppler, Transcranial; Vasodilation; Vasomotor System; Vasospasm, Intracranial	2006
[Medical treatment in peripheral arterial disease: a professional practice study in 262 patients]. La Revue de medecine interne, 2007, Volume: 28, Issue:2 Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medical Records; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Pravastatin; Retrospective Studies; Stroke	2007
Pravastatin, blood pressure, and stroke. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:3 Topics: Anticholesteremic Agents; Arteries; Blood Pressure; Clinical Trials as Topic; Compliance; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Pravastatin; Stroke; Veins	2000
Pravastatin therapy and the risk of stroke. The New England journal of medicine, 2000, Dec-21, Volume: 343, Issue:25 Topics: Anticholesteremic Agents; Coronary Disease; Humans; Pravastatin; Risk Factors; Stroke	2000
Pravastatin therapy and the risk of stroke. The New England journal of medicine, 2000, Dec-21, Volume: 343, Issue:25 Topics: Angina, Unstable; Anticholesteremic Agents; Humans; Myocardial Infarction; Pravastatin; Risk Factors; Stroke	2000
Pravastatin therapy and the risk of stroke. The New England journal of medicine, 2000, Dec-21, Volume: 343, Issue:25 Topics: Angina, Unstable; Anticholesteremic Agents; Humans; Myocardial Infarction; Pravastatin; Risk Factors; Stroke	2000
[Concerning: Devuyst G, Bogousslavsky I. Cholesterol and risk of cerebrovascular accidant: a role for statins?]. Schweizerische medizinische Wochenschrift, 2000, Dec-02, Volume: 130, Issue:48 Topics: Anticholesteremic Agents; Carotid Stenosis; Cholesterol; Cytochrome P-450 Enzyme System; Drug Interactions; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pravastatin; Risk Factors; Roxithromycin; Stroke	2000
Statins for stroke: the second story? Circulation, 2001, Jan-23, Volume: 103, Issue:3 Topics: Anticholesteremic Agents; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Pravastatin; Risk Factors; Simvastatin; Stroke	2001
Suppression of recurrent transient ischemic attacks by a statin agent. Neurology, 2001, Feb-27, Volume: 56, Issue:4 Topics: Aged; Anticholesteremic Agents; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pravastatin; Recurrence; Stroke	2001
Improvement of endothelial function in insulin-resistant carotid arteries treated with pravastatin. Journal of neurosurgery, 2001, Volume: 95, Issue:3 Topics: Animals; Carotid Stenosis; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelium, Vascular; Hypertension; Insulin Resistance; Male; Nitric Oxide; Pravastatin; Rats; Rats, Sprague-Dawley; Risk Factors; Stroke; Vascular Resistance	2001
Poststroke emotional incontinence and decreased sexual activity. Cerebrovascular diseases (Basel, Switzerland), 2002, Volume: 13, Issue:1 Topics: Acute Disease; Affective Symptoms; Chronic Disease; Crying; Female; Follow-Up Studies; Humans; Laughter; Libido; Male; Middle Aged; Pravastatin; Recovery of Function; Sexual Behavior; Sexual Dysfunction, Physiological; Stroke	2002
Lipid-lowering drug use and cardiovascular events after myocardial infarction. The Annals of pharmacotherapy, 2002, Volume: 36, Issue:5 Topics: Cholesterol; Clofibrate; Cohort Studies; Coronary Artery Disease; Coronary Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Niacin; Pravastatin; Risk Factors; Simvastatin; Stroke; Treatment Outcome	2002